Indoco Remedies Limited
INDOCO
Rank in Stocks
#16340
Indoco Remedies Limited, an Indian pharmaceutical company founded in Mumbai in... Indoco Remedies Limited, an Indian pharmaceutical company founded in Mumbai in 1945 (originally known as Indo Continental Trading Company), operates globally, manufacturing and distributing a broad spectrum of finished drug formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses diverse therapeutic areas: Respiratory conditions: with offerings like Karvol Plus, Febrex Plus, and Tuspel. Oral and dental care (stomatologicals): including Sensodent-K, Sensoform Toothpaste, the Rexidin series, and Snowdent. Gastrointestinal ailments: featuring products such as Carmicide, Cyclopam, and Nosic. Pain relief/analgesics: exemplified by Lignox and T-lac. Ophthalmic and otic solutions: comprising items like Renolen, Dexoren β S, and the Mofloren range. Vitamins, minerals, and nutritional supplements: such as Methycal, MCBM DHA, and Apispur. Urological treatments: including Carmicide and Cital. Dermatological preparations: like Cloben G and Scabex. Anti-infective agents: represented by ATM. Blood-related therapies: such as Hemsyl. Gynecological health products: including MCBM 69 and D Chiro. Anti-haemorrhoidal treatments: with Spear. Beyond its pharmaceutical manufacturing, Indoco Remedies provides comprehensive analytical services. These include impurity profiling, particle size analysis, heavy metal analysis, polymorphism studies, compatibility and stability assessments (like extractables/leachables and lyophilization), and advanced chromatographic method development and validation. Furthermore, the company offers a suite of engineering and project management services. This covers architectural and structural design, mechanical and electrical engineering, lighting solutions, control system integration, piping design, data transfer systems, and holistic project and construction management for process facilities. Indoco Remedies serves a wide range of medical professionals, from general practitioners and pediatricians to specialized consultants like dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists.
Share Price
$2.33
Last synced: 2026-11-09
Market Cap
$215.23M
Change (1 day)
2.55%
Change (1 year)
-23.29%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Indoco Remedies Limited (INDOCO)
Category
Healthcare
EPS for Indoco Remedies Limited (INDOCO)
EPS as of September 2026 TTM: $0.04
According to Indoco Remedies Limited's latest financial reports, its current EPS (TTM) is $0.04. At the end of 2025 the company had an EPS of $-0.10, a decrease compared to its 2024 EPS of $0.13.
EPS history for Indoco Remedies Limited from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.04 | -135.70% |
| 2025 | $-0.10 | -178.61% |
| 2024 | $0.13 | -31.83% |
| 2023 | $0.19 | -15.09% |
| 2022 | $0.22 | 60.36% |
| 2021 | $0.14 | 296.55% |
| 2020 | $0.03 | -856.52% |
| 2019 | 0.00 | -106.70% |
| 2018 | $0.07 | -46.70% |
| 2017 | $0.13 | -3.95% |
| 2016 | $0.13 | -6.87% |
| 2015 | $0.14 | 37.37% |
| 2014 | $0.10 | 22.83% |
| 2013 | $0.09 | -13.91% |
| 2012 | $0.10 | -20.32% |
| 2011 | $0.12 | 22.30% |
| 2010 | $0.10 | 51.49% |
| 2009 | $0.07 | -39.19% |
| 2008 | $0.11 | -4.41% |
| 2007 | $0.12 | 65.85% |
| 2006 | $0.07 | -7.19% |
| 2005 | $0.08 | 7.59% |
| 2004 | $0.07 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 18,111.20% |
DE
|
|
| $6.08 | 16,924.09% |
DE
|
|
| $1.55 | 4,243.42% |
JP
|
|
| $3.66 | 10,152.10% |
CH
|
|
| $0.45 | 1,160.50% |
IL
|
Questions about Indoco Remedies Limited's earnings per share (EPS)
What is Indoco Remedies Limited's earnings per share (EPS)?
Indoco Remedies Limited's earnings per share (EPS) over the last twelve months is $0.04, as of Sep 2026.
What was Indoco Remedies Limited's earnings per share (EPS) in 2025?
In 2025, Indoco Remedies Limited's earnings per share (EPS) was $-0.10, compared with $0.13 in 2024.
How has Indoco Remedies Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Indoco Remedies Limited's earnings per share (EPS) was highest in 2022 ($0.22) and lowest in 2025 ($-0.10).
How does Indoco Remedies Limited's earnings per share (EPS) compare with similar companies?
Indoco Remedies Limited's earnings per share (EPS) ($0.04) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.